- Home
- WSBF vs MXCT Comparison
WSBF vs MXCT Comparison
Compare WSBF & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBF
- MXCT
- Stock Information
- Founded
- WSBF 1921
- MXCT 1999
- Country
- WSBF United States
- MXCT United States
- Employees
- WSBF N/A
- MXCT N/A
- Industry
- WSBF Savings Institutions
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WSBF Finance
- MXCT Health Care
- Exchange
- WSBF Nasdaq
- MXCT Nasdaq
- Market Cap
- WSBF 240.7M
- MXCT 239.2M
- IPO Year
- WSBF N/A
- MXCT 2021
- Fundamental
- Price
- WSBF $13.46
- MXCT $2.06
- Analyst Decision
- WSBF
- MXCT Strong Buy
- Analyst Count
- WSBF 0
- MXCT 1
- Target Price
- WSBF N/A
- MXCT $9.00
- AVG Volume (30 Days)
- WSBF 45.6K
- MXCT 922.0K
- Earning Date
- WSBF 07-24-2025
- MXCT 08-05-2025
- Dividend Yield
- WSBF 4.46%
- MXCT N/A
- EPS Growth
- WSBF 95.86
- MXCT N/A
- EPS
- WSBF 1.02
- MXCT N/A
- Revenue
- WSBF $133,551,000.00
- MXCT $37,675,000.00
- Revenue This Year
- WSBF N/A
- MXCT $8.82
- Revenue Next Year
- WSBF N/A
- MXCT $21.12
- P/E Ratio
- WSBF $13.23
- MXCT N/A
- Revenue Growth
- WSBF 1.81
- MXCT N/A
- 52 Week Low
- WSBF $11.61
- MXCT $2.03
- 52 Week High
- WSBF $16.86
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- WSBF 60.02
- MXCT 39.29
- Support Level
- WSBF $13.21
- MXCT $2.19
- Resistance Level
- WSBF $13.88
- MXCT $2.28
- Average True Range (ATR)
- WSBF 0.20
- MXCT 0.12
- MACD
- WSBF -0.00
- MXCT 0.00
- Stochastic Oscillator
- WSBF 64.10
- MXCT 7.81
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.